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Glucose Metabolism in Mouse Tumor and Liver With and Without 
Hyperthermiat 
christian Streffer,* Sieglinde Hengstebeck,* and Peter Tamulevicius* 
We measured levels of glycolytic metabolites in mouse 
tumor and liver after administering a glucose load of 6 
mg/g of body weight and after hyperthermia for one hour at 
43°C. Metabolites included glucose, glucose-6-phos-
phate, fructose-1.6-diphosphate, dihydroxyacetone-phos-
phate, glycerol-3-phosphate, pyruvate, and lactate, as well 
as acetoacetate and ^hydroxybutyrate. 
The combined treatment led to an increase of the lactate 
level and apparently enhanced glucose degradation. The 
redoxequilibria states were shifted to the reduced meta-
bolites. It is possible that hypoxia was induced or en-
hanced, which could have significance for tumor therapy. 
At later periods after hyperthermia, metabolic alterations 
occurred that have also been observed in severe diabetes. 
These alterations occurred in the liver as well. In both 
situations, such alterations must be considered in connec-
tion with potential damage to normal tissue from 
hyperthermia. 
M e t a b o l i c pathways are very well regulated. If tempera-
ture changes alter the rate of enzymatic reactions, disorders 
of the whole pathway can occur. At very high tempera-
tures, denaturation of proteins takes place (1). Damage to 
cancer cell metabolism by hyperthermia has been reported 
(2,3). Von Ardenne has suggested thatthe heat sensitivity of 
cancer cells can be increased by glucose (4,5). It is as-
sumed that lactate accumulates under these conditions and 
lowers intracellular pH. In addition, other authors have 
shown that lowering of the pH value causes a remarkable 
enhancement of cell killing by hyperthermia (6). 
Because glucose metabolism is coupled in several complex 
ways with the described parameters, it seemed of interest to 
study its alteration by hyperthermia in an experimental 
tumor. Tumor therapy is very strongly linked to the toler-
ance of normal tissues. As glucose metabolism is especially 
active in liver, hepatic tissue is included in these studies. 
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An adenocarcinoma was transplanted into inbred mice (C57 
black) by injecting a tumor cell suspension into the mus-
cles of the hind leg. Six days after transplantation, hyper-
thermia studies were carried out. Glucose (6 mg/g body 
weight) was injected intraperitoneally directly before the 
hyperthermia treatment began. 
After the mice had been anesthetized, the tumor was 
heated in a water bath for one hour at 43°C. Temperatures 
were measured in the tumor and in the neck. In the tumor, 
the temperature increased from 35.2°C to 42.0°C within 10 
minutes. After 30 minutes of heating, it reached 42.7°C and 
stayed at this temperature until the end of heating. After the 
treatment was completed, the temperature dropped to less 
than 30°C and remained at this low level for several hours. 
In the neck, the temperature also increased to 40.4°C 
wfthin 30 minutes of heating at 43°C. After treatment, the 
rectal temperature fell to about 32°C for several hours. 
Forthe metabolic determinations, both the liver tissue and 
the tumor were removed under anesthesia, homogenized 
with 4% perchloric acid, and centrifuged. The supernatant 
was neutralized and used for the determination of glucose, 
glucose-6-phosphate (G-6-P), fructose-1.6-diphosphate 
(FDP), dihydroxy-acetonephosphate (DAP), glycerol-3-
phosphate (G-3-P), pyruvate, lactate, acetoacetate (AcAc), 
and )8-hydroxybutyrate (/3-HO-Bu). The metabolites were 
measured by enzymatic assays coupled to N A D + o r 
NADH (7). 
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Results and Discussion 
After the intraperitoneal injection of glucose in a rather 
high dose (Table I), the glucose level in the liver tissue 
increased very rapidly and reached its highest level within 
10 minutes. After 60 minutes, the glucose level had de-
creased again. In the hepatic tissue, most of the measured 
glycolytic metabolites were not considerably altered; only 
pyruvate and lactate, the end products of glycolysis, were 
enhanced. 
When the hyperthermia treatment was started just after the 
glucose injection, the glucose content in the liver was the 
same as without hyperthermia. However, the levels of 
glycerol-3-phosphate, pyruvate, lactate, and /3-hydrox-
ybutyrate had increased. As mentioned earlier, the local 
heating induced a rise of the temperature in the whole 
mouse to about 40°C (Table I). These data demonstrate the 
difficulties in heating tissues locally, and, as a conse-
quence, in limiting the effects of hyperthermia to the local 
tumor. 
The problem of heat dissipation is especially acute with 
smaller animals such as the mouse and wil l be less serious 
in clinical tumor therapy, although it does exist. 
In the tumor tissue, glucose increased at about the same 
rate as in the liver (Table II). The highest levels were 
obtained 20-40 minutes after the injection (about 14/u. 
moles/g tissue). The increases in lactate and in FDP and 
DAP levels were comparatively small. 
With hyperthermia, the glucose and G-6-P in the tumor 
were reduced, while G-3-P and ^-hydroxybutyrate were 
increased. Similar changes in G-3-Pand /3-hydroxybutyrate 
occurred when a glucose load was given just before the 
hyperthermia treatment was started. However, under these 
conditions (glucose plus hyperthermia), the lactate content 
was also enhanced in the tumor directly after the hyper-
thermia treatment had ended. 
Dickson and Calderwood (8) observed that glycolysis in 
Yoshida sarcoma of rats was inhibited after hyperthermia 
treatment in vivo when the tumor tissue was incubated in 
vitro. Our data appear not to support such a mechanism for 
the period during hyperthermia, because our finding that 
the glucose level was lowered by hyperthermia demon-
strates a more rapid glucose turnover. In other experiments 
with mice, we found that the output of ^''C02 increased 
during whole body hyperthermia (one hour at 40°C or 
41 °C) after radioactive-labelled glucose was injected (un-
published results). We have also observed that during 
whole body hyperthermia a considerable breakdown of 
hepatic glycogen occurred, and no accumulat ion of 
glycolytic metabolites was found (9). However, some 
hours after hyperthermia the metabolic degradation of 
glucose was apparently decreased, an effect which agrees 
with the data of Dickson and Calderwood (8) and which 
wil l be discussed later. It was further surprising that most of 
the glycolytic metabolites besides lactate increased very 
little. 
When we studied rats with a transplantable glioblastoma 
after chronic glucose infusion, we found a higher rise of 
G-6-P FDP and DAP, which coincided with a decrease of 
the pH value (unpublished results). These data suggest that 
if hyperthermia inhibits glucose degradation, lactate con-
sumption may be somewhat reduced. 
TABLE I 
Content of Metabolites* in Mouse Liver After Glucose Injection and Hyperthermia 
Glucose** and 
Glucose*' Glucose** hyperthermia 
Control 10 min 60 min 60 min 
Glucose 10.2 ±0.2 37.0 ±3.0 23.9 ±2.0 23.4 ±0.1 
G-6-P 0.36 ±0.01 0.42 ±0.02 0.36 ±0.02 0.32 ±0.02 
FDP 0.038 ±0,003 0.031 ±0.002 0.041 ±0.02 0.034 ±0.002 
DAP 0.035 ±0.001 0.035 ±0,002 0.043 ±0.02 0.038 ±0.002 
G-3-P 0.52 ±0.02 0.51 ±0.02 0.70 ±0.05 1.35 ±0.06 
Pyruvate 0.047 ±0.003 0.119 ±0.011 0.10 ±0.01 0.13 ±0.01 
Lactate 1.95 ±0.09 3.29 ±0.15 3.67 ±0.13 6.10 ±0.17 
AcAc 0.049 ±0.004 0.053 ±0.007 0.061 ±0.005 0.060 ±0.005 
/3-HO-Bu 0.19 ±0.01 0.16 ±0.01 0.17 ±0.01 0.32 ±0.02 
G-3-P/DAP 14.8 14.6 16.3 35.5 
Lact/Pyruvate 41.5 27.5 36.7 47.0 
;8-H0-Bu/AcAc 3.9 3.0 2.8 5.3 
* fL moles/g tissue 
** 6 mg/g body weight 
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Glucose Metabolism and Hyperthermia 
It should also be ment ioned that hyper thermia plus glucose 
shifted the redoxequi l ibr ia state in the d i rect ion of the 
reduced metaboli tes (Tables I and II) for the ratios of both 
lactate/pyruvate and /3-hydroxybutyrate/acetoacetate, es-
pecia l ly in the tumor. This shift cou ld mean that hypox ia 
was induced or enhanced under these condi t ions and 
cou ld have some relevance to the pH value through the 
f o l l ow ing equat ion : 
1^  ^ [ lactate] x [ N A D +] 
[pyruvate] X [ N A D H ] [ H +] 
Analogous equat ions are val id fo r the other redoxequi l ibr ia 
states. Such changes w o u l d have a great signif icance for 
tumor therapy and must be investigated further. 
In further exper iments, the metabol i tes were measured 
over a 12-hour per iod after hyper thermia treatment w i thou t 
glucose in ject ion (Table 111). Glucose content decreased 
sharply, fo l l owed by the other g lycolyt ic metaboli tes in-
c lud ing lactate and pyruvate. Dur ing this per iod, the CO2 
output f rom glucose was also d imin ished (unpubl ished 
results). However , two other strong acidic metaboli tes, 
TABLE II 
Content of Metabolites* in Transplanted Adenocarcinomas After 








60 min after injection 
= directly after 
hyperthermia 
Glucose 3.12 ±0.10 1.19 ±0.14 10.96 ±1.19 7.99 ±0.47 
G-6-P 1.02 ±0.03 0.65 ±0.04 0.70 ±0.03 1.10 ±0.10 
FDP 0.030 ±0.001 0.027 ±0.003 0.048 ±0.002 0.061 ±0.002 
DAP 0.036 ±0.001 0.030 ±0.002 0.046 ±0.002 0.054 ±0.002 
G-3-P 0.37 ±0.01 0.50 ±0.02 0.36 ±0.01 0.58 ±0.01 
Pyruvate 0.22 ±0.01 0.22 ±0.01 0.20 ±0.01 0.17 ±0.01 
Lactate 14.3 ±0.3 13.1 ±0.5 16.5 ±0.5 26.5 ±0.6 
AcAc 0.017 ±0.002 0.016 ±0.003 0.018 ±0.002 0.014 ±0.002 
/3-HO-Bu 0.097 ±0.007 0.159 ±0.008 0.069 ±0.004 0.15 ±0.01 
G-3-P/DAP 10.2 16.7 7.8 10.4 
Lact/Pyruvate 65 60 82 1 56 
/3-HO-Bu/AcAc 5.7 10.0 3.8 10.7 
' f l moles/g tissue 
' 6 mg/g body weight 
TABLE III 
Content of Metabolites* in Transplanted Adenocarcinomas After Hyperthermia 
Control 1 hour 6 hours 12 hours 
Glucose 3.12 ±0.10 1.59 ±0.12 1.35 ±0.08 1.04 ±0.064 
G-6-P 1.02 ±0.03 0.70 ±0.04 0.90 ±0.046 0.44 ±0.036 
FDP 0.030 ±0.001 0.022 ±0.002 0.027 ±0.001 0.017 ±0.001 
DAP 0.036 ±0.001 0.029 ±0.002 0.029 ±0.002 0.023 ±0.002 
G-3-P 0.37 ±0.01 0.31 ±0.01 0.37 ±0.02 0.28 ±0.012 
Pyruvate 0.22 ±0.01 0.24 ±0.01 0.17 ±0.01 0.11 ±0.01 
Lactate 14.3 ±0.3 11.9 ±0.4 12.1 ±0.4 7.90 ±0.30 
AcAc 0.017 ±0.002 0.041 ±0.007 0.058 ±0.009 0.19 ±0.02 
/3-HO-Bu 0.097 ±0.007 0.249 ±0.027 0.338 ±0.030 0.75 ±0.07 
G-3-P/DAP 14.8 10.7 12.8 12.1 
Lact/Pyr 41.5 49.6 36.7 46.7 
;3-H0-Bu/AcAc 3.9 6.1 5.9 4.9 
* f l moles/g tissue 
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acetoacetate and j8-hydroxybutyrate, were greatly in-
creased after hyperthermia. Similar observations were 
made in the liver tissue of mice after whole body hyper-
thermia (9). Thus, metabolic alterations occurred which 
were also found in severe diabetes. These might also 
contribute to the liver damage which has been observed 
after clinical hyperthermia applications. The acidic meta-
bolites could be formed from glucose via lactate and 
acetyl-CoA or from fatty acids. 
Thus, glucose metabolism might be important for two 
reasons. First, the sensitivity of the tumor tissue to hyper-
thermia might be altered so that blood flow and the oxygen 
supply can be influenced concomitantly. Second, hyper-
thermia may induce changes in glucose metabolism over a 
longer period which could contribute to pathophysiologi-
cal damage in normal tissues. 
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